Information Library

Results for: Oncology - Patient & Investigator Recruitment

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Turkey Oncology Capabilities

    Brochure — February 6, 2012
    Turkey has outstanding access to patients with a population of almost 75 million. Quintiles recent experience demonstrates Turkey provides rapid patient enrollment with high patient retention rates and remains an emerging market with few competing studies – becoming a major hub for patient recruitment.

  • Middle East Oncology capabilities

    Brochure — February 6, 2012
    Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates.

  • Harish Dave Discusses ASH 2011

    Hear from the Experts — December 8, 2011
    Harish Dave discusses the American Society of Hematology annual meeting.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Clinical Trials: Race to Study Launch & Speed to Finish

    Presentation — July 2, 2010
    Chris Cabell's presentation at DIA US 2010 - Clinical Trials:Race to Study Launch and Speed to Finish

  • Breakthrough Motivation

    Case Study — June 24, 2010
    Quintiles' Expertise, Network Maximize Recruitment

  • Strategic Communication

    Case Study — June 24, 2010
    Exceeding Global Recruitment Targets - 6 Months Early

  • Extraordinary Results

    Case Study — June 24, 2010
    9-Month Savings Nets 50% More Patients

  • Data-Driven Patient Recruitment

    White Paper — March 23, 2010
    Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials.

  • Sub-Saharan Africa Phase II/III Fact Sheet

    Brochure — July 29, 2009
    Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.

Page 1 of 2 (12 results)

Subscribe to Email Based on Your Interests

Set preferences